These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24588525)

  • 1. Letter to the editor: Re: Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy.
    Chava VK; Samudrala P
    J Periodontol; 2014 Mar; 85(3):372. PubMed ID: 24588525
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor: Authors' response.
    Mayer Y; Elimelech R; Machtei EE
    J Periodontol; 2014 Mar; 85(3):372-3. PubMed ID: 24588524
    [No Abstract]   [Full Text] [Related]  

  • 3. Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy.
    Mayer Y; Elimelech R; Balbir-Gurman A; Braun-Moscovici Y; Machtei EE
    J Periodontol; 2013 Feb; 84(2):136-42. PubMed ID: 22524332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
    Mayer Y; Balbir-Gurman A; Machtei EE
    J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders.
    Onel KB; Onel K
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1024-8. PubMed ID: 20506257
    [No Abstract]   [Full Text] [Related]  

  • 6. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
    Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
    Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies.
    Peters MJ; Watt P; Cherry L; Welsh P; Henninger E; Dijkmans BA; McInnes IB; Nurmohamed MT; Sattar N
    Ann Rheum Dis; 2010 Sep; 69(9):1687-90. PubMed ID: 19640853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis and accelerated atherogenesis.
    Gonzalez-Juanatey C; Gonzalez-Gay MA
    Circulation; 2004 Jun; 109(25):e328; author reply e328. PubMed ID: 15226238
    [No Abstract]   [Full Text] [Related]  

  • 9. Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis.
    Fabri GM; Pereira RM; Savioli C; Saad CG; de Moraes JC; Siqueira JT; Bonfa E
    J Clin Rheumatol; 2015 Oct; 21(7):341-5. PubMed ID: 26398459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case records of the Massachusetts General Hospital. Case 22-2011. A 79-year-old man with a rash, arthritis, and ocular erythema.
    Kroshinsky D; Stone JH; Nazarian RM
    N Engl J Med; 2011 Jul; 365(3):252-62. PubMed ID: 21774714
    [No Abstract]   [Full Text] [Related]  

  • 11. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy.
    Chambers CD; Johnson DL
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):607-11. PubMed ID: 22786755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF therapy: where have we got to in 2005?
    Feldmann M; Brennan FM; Foxwell BM; Taylor PC; Williams RO; Maini RN
    J Autoimmun; 2005; 25 Suppl():26-8. PubMed ID: 16260118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C; Ribeiro AC; Fabri GM; Calich AL; Carvalho J; Silva CA; Viana VS; Bonfá E; Siqueira JT
    J Clin Rheumatol; 2012 Jun; 18(4):180-4. PubMed ID: 22647860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
    Joyau C; Veyrac G; Dixneuf V; Jolliet P
    Clin Exp Rheumatol; 2012; 30(5):700-6. PubMed ID: 22935567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases.
    Skurkovich S; Skurkovich B
    Ann N Y Acad Sci; 2005 Jun; 1051():684-700. PubMed ID: 16127009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological adverse events under anti-TNF alpha therapy].
    Cohen M; Baldin B; Thomas P; Lebrun C
    Rev Neurol (Paris); 2012 Jan; 168(1):33-9. PubMed ID: 22098827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the use of tumor necrosis factoralpha inhibitors in refractory uveitis.
    Sebastian RT; Harding SP; Bucknall RC; Pearce IA
    Arch Ophthalmol; 2006 Oct; 124(10):1505; author reply 1505-6. PubMed ID: 17030729
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the editor: re: reliability of partial-mouth recording systems to determine periodontal status: a pilot study in an adult portuguese population.
    Park JB; Park YG
    J Periodontol; 2015 May; 86(5):607. PubMed ID: 25904065
    [No Abstract]   [Full Text] [Related]  

  • 20. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
    Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.